Show Stocks and Investing Publications • Fri, November 3, 2023
Joseph Stringer Maintained (VIR) at Strong Buy with Decreased Target to $15 on, Nov 3rd, 2023
aintained-vir-at-strong-buy-with-decreased-target-to-15-on-nov-3rd-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIJoseph Stringer of Needham, Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $22 to $15 on, Nov 3rd, 2023.
Joseph has made no other calls on VIR in the last 4 months.
There are 5 other peers that have a rating on VIR. Out of the 5 peers that are also analyzing VIR, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoff Meacham of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $14 on, Friday, September 8th, 2023
- Michelle Gilson of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, July 21st, 2023
These are the ratings of the 3 analyists that currently disagree with Joseph
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $95 on, Monday, August 7th, 2023
- Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $28 on, Friday, July 21st, 2023
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $41 on, Friday, July 21st, 2023
Like: 👍